Novocure Receives FDA Approval for Second Generation Optune System
Go back to Novocure Receives FDA Approval for Second Generation Optune System| (NASDAQ: NVCR) | Delayed: 15.51 +0.16 (1.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.35 | 52 Week High | $28.95 | |||
| Open | $15.50 | 52 Week Low | $5.95 | |||
| Day High | $16.00 | P/E | N/A | |||
| Day Low | $15.35 | EPS | $0.00 | |||
| Volume | 1,127,184 | |||||
